The SME IPO of Medicamen Organics commenced its subscription on Friday and is scheduled to conclude on June 24. The company intends to raise approximately Rs 10.54 crore through this offering. Once successfully subscribed, the shares will be listed on the BSE SME platform.
Muted Q4, weak forecast cast a shadow on HCLTech
HCLTech’s revenue growth guidance for FY27 is significantly lower than the actual FY26 growth, implying the effect of growing dependence of clients on operating efficiencies